Abstract
To evaluate the effects of mannitol on aqueous flare (aqueous protein concentration), we administered an intravenous clinical therapeutic dose to normal young adults (average age 20.1 years), to normal older adults (average age 61.5 years), and also to patients with diabetes mellitus, systemic hypertension, or pseudoexfoliation syndrome who were about to undergo intraocular surgery (average age 66.4 years). Protein and cell levels in the aqueous were determined with a device that measures laser light scatter in the aqueous. Mannitol increased the intensity of aqueous flare. In all subjects, the intensity of aqueous flare was greatest around 1 h following drug administration; the magnitude and duration of the aqueous flare increase were significantly greater in normal older adults than in normal young adults; the magnitude was essentially the same in older adults with and without disease. The effect reversed within 6 h of drug administration in normal subjects. We consider the findings to represent changes in actual aqueous protein concentration and discuss the possible causes of this phenomenon.
Similar content being viewed by others
References
Adams RE, Kirschner RJ, Leopold IH (1963) Ocular hypotensive effect of intravenous administered mannitol. Arch Ophthalmol 65:55–58
Brooks AMV, Gilles WE (1983) Fluorescein angiography and fluorophotometry of the iris in pseudoexfoliation of the lens capsule. Br J Ophthalmol 67:249–254
Duncan LS, Ellis PP, Paterson CA (1970) Effect of hyperosmotic agents on vitreous osmolality. Exp Eye Res 10:129–132
Friedman B, Byron H, Turtz A (1962) Urea in cataract extraction. Arch Ophthalmol 67:421–423
Galin MA, Baras I (1961) Intravenous urea in retinal detachment surgery. Arch Ophthalmol 65:652–656
Galin MA, Aizawa F, McLean J (1959) Urea as an osmotic ocular hypotensive agent in glaucoma. Arch Ophthalmol 62:347–352
Galin MA, Nano H, Davidson R (1961) Aqueous and blood urea nitrogen levels after intravenous urea administration. Arch Ophthalmol 65:805–807
Galin MA, Davidson R, Shachter N (1966) Ophthalmological use of osmotic therapy. Am J Ophthalmol 62:629–634
Havener WH (1983) Osmotic agents. In ocular pharmacology Mosby, St. Louis, pp 539–564
Ishibashi T, Tanaka K, Taniguchi Y (1982) Disruption of the iridial blood-aqueous barrier in experimental diabetic rats: an electromicroscopic study. Acta Soc Ophthalmol Jpn 33:243–252
Kayawaza F, Miyake K (1984) Ocular fluorophotometry in patients with essential hypertension. Arch Ophthalmol 102:1169–1170
Kawasaki K, Yamamoto S, Yonemura D (1977) Electrophysiological approach to clinical test for the retinal pigment epithelium. Acta Soc Ophthalmol Jpn 81:1303–1312
Kraff MC, Sanders DR, Peyman GA, Lieberman HL, Tarabishy S (1980) Slit lamp fluorophotometry in intraocular lens patients. Ophthalmology 87:877–880
Krupin T, Waltman SR, Oestrich C (1978) Vitreous fluorophotometry in juvenile-onset diabetes mellitus. Arch Ophthalmol 96:812–814
Laties AM, Rapoport S (1976) The blood-ocular barriers under osmotic stress. Arch Ophthalmol 94:1086–1091
Miyake K (1982) Blood-retinal barrier in eyes with long-standing aphakia with apparently normal fundi. Arch Ophthalmol 100:1437–1439
Miyake K (1991) Fluorophotometry in implant surgeries. Proceedings of the Fourth International Congress on Cataract and Refractive Microsurgery. Florence, Italy (in press)
Miyake K, Asakura M, Kobayashi H (1984) Effect of intraocular lens fixation on the blood-aqueous barrier. Am J Ophthalmol 98:451–455
Miyake K, Asakura M, Maekubo K (1984) Consensual reaction of human blood-aqueous barrier to implant surgeries. Arch Ophthalmol 102:558–561
Miyake Y, Miyake K, Maekubo K, Kayazawa F (1989) Increase in aqueous flare by a therapeutic dose of mannitol in humans. Acta Soc Ophthalmol Jpn 93:1149–1153
Neuwelt EA, Frenkel EP, Rapoport S, et al (1980) Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog. Neurosurgery 7:36–43
Neuwelt EA, Barnett PA, Bigner DD, et al (1982) Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent. The factor of the blood-brain barrier. Proc Natl Acad Sci USA 79:4420–4423
Okisaka S, Kuwabara T, Rapoport SI (1976) Effect of hyperosmotic agents on the ciliary epithelium and trabecular mesh-work. Invest Ophthalmol Vis Sci 15:617–625
Sanders DR, Kraff MC, Lieberman HL, Peyman GA, Tarabishy S (1982) Breakdown and reestablishment of blood-aqueous barrier with implant surgery. Arch Ophthalmol 100:588–590
Sawa M, Sakanishi Y, Shimizu H (1984) Fluorophotometric study of anterior segment barrier functions after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Am J Ophthalmol 97:197–204
Sawa M, Tsurumaki Y, Tsuru T, Shimizu H (1988) New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol 32:132–142
Shabo A, Maxwell D, Kreiger A (1976) Structural alterations in the ciliary process and blood-aqueous barrier of the monkey after systemic urea injections. Am J Ophthalmol 81:162–172
Tarter RC, Linn JG (1961) A clinical study of the use of intravenous urea in glaucoma. Am J Ophthalmol 52:323–331
Tornquist P, Ring A (1980) The influence of hyperosmotic stress on the blood-retinal barrier. Effects on the electroretinogram. Acta Ophthalmol 58:707–711
Tso MOM, Shih CY (1977) Experimental macular edema after lens extraction. Invest Ophthalmol Vis Sci 16:381–392
Unger WG, Cole DF, Hammond B (1975) Disruption of the blood-aqueous barrier following paracentesis in the rabbit. Exp Eye Res 20:255–270
Yamashita H, Uyama M, Sears ML (1981) Comparative study by electron microscopy of response to urea between ciliary epithelia of albino and pigmented rabbits — a function of the ciliary pigmented epithelium. Jpn J Ophthalmol 25:312–320
Author information
Authors and Affiliations
Additional information
Offprint requests to: K. Miyake
Rights and permissions
About this article
Cite this article
Miyake, K., Miyake, Y. & Maekubo, K. Increased aqueous flare as a result of a therapeutic dose of mannitol in humans. Graefe's Arch Clin Exp Ophthalmol 230, 115–118 (1992). https://doi.org/10.1007/BF00164647
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00164647